This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Francisco J. Puga, MD; John S. Welch, MD; Harry F. Bisel, MD

Arch Surg. 1976;111(8):877-880.

Abstract
• Of 145 women with metastatic breast carcinoma who survived palliative surgical castration, 40.7% had objective remission and another 11.0% had subjective improvement. Favorable response was more frequent in ovulating patients who had small masses of recurrent tumor in fewer locations, with skeletal spread especially well tolerated. Palliation appeared to be related to the site of metastatic disease and numbers (mass) of metastatic sites, but not to the age of the patient, tumor histology, or the disease-free interval. Survival was better for the patients who showed improvement after castration. Such improvement may predict continued relief from the use of other modalities of systemic treatment.

(Arch Surg 111:877-880, 1976)

Author Affiliations
From the Department of Surgery and the Division of Clinical Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Accepted for publication April 2, 1976.

Reprint requests to Section of Publications, Mayo Clinic, Rochester, MN 55901 (Dr Puga).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?